Chlamydia in colposcopy clinics: to screen or not to screen?

References

• Adler M W. Sexual health-health of the nation; a decade later – a further failure. Sexually Transmitted Infections 2003; 79: 85–87
   PubMed Web of Science ®Google Scholar
• Allerding T J, Jordan S W, Boardman R E. Association of human papillomavirus and Chlamydia infections with the incidence of cervical neoplasia. Acta Cytologica 1985; 29: 653–660
   PubMedGoogle Scholar
• Blackwell A, Linton D, Emery S, Calvert J. Chlamydia trachomatis infection in a colposcopy unit: an audit of fast track referral system for infected patients to a genitourinary medicine department and a survey of patients' demography, clinical findings and partner details. International Journal of STD and AIDS 2003; 14: 661–664
   PubMedGoogle Scholar
• Boyle D CM, Smith J R. Infection and cervical intraepithelial neoplasia. International Journal of Gynecological Cancer 1999; 9: 177–186
   PubMedGoogle Scholar
• Byrne M A, Turner M J, Griffiths M, Taylor-Robinson D, Soutter W P. Evidence that patients with dyskaryotic cervical smears should be screened for genital tract infections other than human papilloma virus infection. European Journal of Obstetrics and Gynaecology and Reproductive Biology 1991; 41: 129–133
   PubMedGoogle Scholar
• Cheema M A, Rahman M U, Whitum-Hudson J A, Hudson A P. Rapid communication: Cervical chlamydia trachomatis in women at low risk for infection. American Journal of Medical Sciences 2000; 319: 123–125
   PubMedGoogle Scholar
• Chernesky M, Jang D, Lee H, Burczak J D, Hu H, Sellors J, et al. Diagnosis of chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. Journal of Clinical Microbiology 1994; 32: 2682–2685
   PubMed Web of Science ®Google Scholar
• De Sanjosé S, Muñoz N, Bosch F X, Reimann K, Pedersen N S, Orfila J, et al. Sexually transmitted agents and cervical neoplasia in Columbia and Spain. International Journal of Cancer 1994; 56: 358–363
   PubMed Web of Science ®Google Scholar
• Department of Health (DOH). Summary and conclusions of CMO's Expert Advisory Group on chlamydia trachomatis. Department of Health, London 1998
   Google Scholar
• Greenhouse P. Prevention of PID: Too little too late. Trends in Urology Gynecology and Sexual Health 1996; 55: 17–18
   Google Scholar
• Hughes G, Simms I, Rogers P A, Swan A V, Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Communicable Disease Report (CDR Supplement) 1998; 8: S1–S11
   PubMedGoogle Scholar
• Johnston A R, Fenton K A. Trends in sexually transmitted infections. Trends in Urology Gynaecology and Sexual Health 2004; 9: 14–19
   Google Scholar
• Labeja-Acellam E T, Harris V G. A study to evaluate chlamydia screening in colposcopy clinics. Journal of Obstetrics and Gynecology 1997; 17: 472–475
   PubMedGoogle Scholar
• Lanham S, Herbert A, Basarab A, Watt P. Detection of cervical infections in colposcopy clinic patients. Journal of Clinical Microbiology 2001; 39: 2946–2950
   PubMedGoogle Scholar
• Lindsay D T, Trounson A O, Anderson A N. Female infertility; causes and treatment. Lancet 1994; 343: 1539–1544
   PubMedGoogle Scholar
• Macmillan S, Mckenzie H, Flett G, Templeton A. Which women should be tested for Chlamydia trachomatis?. British Journal of Obstetrics and Gynaecology 2000; 107: 1088–1093
   Google Scholar
• Mahony J B, Luinstra K E, Tyndall M, Sellors J W, Krepel J, Chernesky M. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary specimens. Journal of Clinical Microbiology 1995; 33: 3049–3053
   PubMedGoogle Scholar
• Mecsei R, Haugen O A, Halvorsen L E, Dalen A. Genital chlamydia trachomatis infections in patients with abnormal cervical smears: effect of tetracycline treatment on cell changes. Obstetrics and Gynecology 1989; 73: 317
   PubMedGoogle Scholar
• National Health Service Cervical Screening programme (NHSCSP). Colposcopy and Programme Management. D Luesley, S Leeson. NHS Cancer screening Programme, Sheffield 2004, Publication No 20
   Google Scholar
• Paavonen J. Is screening for chlamydia trachomatis infection cost effective?. Genitourinary Medicine 1997; 73: 103–104
   PubMedGoogle Scholar
• Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human Reproduction Update 1999; 5: 433–447
   PubMed Web of Science ®Google Scholar
• Pearlman M D, Mcneely S G. A review of microbiology, immunology and clinical implications of chlamydia trachomatis infections. Obstetrical and Gynecological Survey 1992; 47: 448–461
   PubMedGoogle Scholar
• Pimenta J M, Catchpole M, Rogers P A, Hopwood J, Randall S, Mallinson H, et al. Opportunistic screening for genital chlamydial infection. II: Prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sexually Transmitted Infections 2003; 79: 22–27
   PubMed Web of Science ®Google Scholar
• Schachter J, Hill E C, King E B, Heilbron D C, Ray R M, Margolis A J, et al. Chlamydia trachomatis and cervical neoplasia. Journal of the American Medical Association 1982; 248: 2134–2138
   PubMed Web of Science ®Google Scholar
• Smith J R, Murdoch J, Carrington D, Frew C E, Dougall A J, Mackinnon H, et al. Prevalence of chlamydia trachomatis infection in women having cervical smear tests. British Medical Journal 1991; 302: 82–84
   PubMedGoogle Scholar
• Syrjänen K, Mäntyjärvi R, Väyrynen M, Castren O, Yliskoski M, Saarikoskis S. Chlamydial cervicitis in women followed-up for human papilloma virus (HPV) lesions of the uterine cervix. Acta Obstetrica et Gynecologica Scandinavica 1985; 64: 467–471
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Mäntyjärvi R, Väyrynen M, Parkkinnen S, Holopainen H, Syrjanen S, et al. Coexistent chlamydial infections related to natural history of human papilloma virus lesions in uterine cervix. Genitourinary Medicine 1986; 62: 345–351
   PubMedGoogle Scholar
• Thompson S E, Washington E. Epidemiology of sexually transmitted chlamydia trachomatis infections. Epidemiologic reviews 1983; 5: 96–123
   PubMed Web of Science ®Google Scholar